Es gab 50 kürzliche Insider-Transaktionen für Cassava Sciences, Inc. (SAVA), darunter 38 Käufe und 6 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $51.4M und die gesamten Insider-Verkäufe auf $5.53M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Gussin Robert Z, O Donnell Michael J, Nicaise Claude. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SAVA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-05-23 |
Gussin Robert Z |
Director |
RSU-Zuteilung |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
O Donnell Michael J |
Director |
RSU-Zuteilung |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
Nicaise Claude |
Director |
RSU-Zuteilung |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
Gravier Pierre |
Director |
RSU-Zuteilung |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-05-23 |
Anderson Robert Eugene Jr |
Director |
RSU-Zuteilung |
26,500 |
$2.11 |
$55.92K |
26,500 |
| 2025-04-17 |
Schoen Eric |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
$1.44 |
$144K |
100,000 |
| 2025-04-17 |
Barry Richard |
President & CEO |
RSU-Zuteilung |
350,000 |
$1.44 |
$504K |
350,000 |
| 2025-04-17 |
Cook Robert Christopher |
Chief Operating & Legal Office |
RSU-Zuteilung |
100,000 |
$1.44 |
$144K |
100,000 |
| 2025-04-17 |
Nassif Freda |
Chief Business Officer |
RSU-Zuteilung |
100,000 |
$1.44 |
$144K |
100,000 |
| 2024-11-29 |
Schoen Eric |
Chief Financial Officer |
Optionsausübung (Verkauf) |
50,000 |
$1.18 |
$59K |
- |
| 2024-11-29 |
Kupiec James William |
Chief Medical Officer |
Informierter Verkauf |
4,000 |
$3.87 |
$15.48K |
- |
| 2024-11-18 |
Nassif Freda |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-11-18 |
Nassif Freda |
Chief Commercial Officer |
RSU-Zuteilung |
100,000 |
$27.95 |
$2.8M |
100,000 |
| 2024-11-18 |
Landen Jaren |
Chief Clinical Dev. Officer |
Unbekannt |
15,000 |
$26.57 |
$398.55K |
- |
| 2024-11-18 |
Landen Jaren |
Chief Clinical Dev. Officer |
RSU-Zuteilung |
85,000 |
$27.95 |
$2.38M |
85,000 |
| 2024-10-01 |
Barry Richard |
President & CEO |
RSU-Zuteilung |
600,000 |
$27.42 |
$16.45M |
600,000 |
| 2024-09-06 |
Schoen Eric |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
$26.91 |
$2.69M |
100,000 |
| 2024-09-06 |
Kupiec James William |
Chief Medical Officer |
RSU-Zuteilung |
100,000 |
$26.91 |
$2.69M |
100,000 |
| 2024-09-06 |
Cook Robert Christopher |
SVP & General Counsel |
RSU-Zuteilung |
100,000 |
$26.91 |
$2.69M |
100,000 |
| 2024-05-20 |
Barbier Remi |
President & CEO |
RSU-Zuteilung |
50,000 |
$22.10 |
$1.11M |
50,000 |
| 2024-05-20 |
Schoen Eric |
Chief Financial Officer |
RSU-Zuteilung |
25,000 |
$22.10 |
$552.5K |
25,000 |
| 2024-05-20 |
Kupiec James William |
Chief Medical Officer |
RSU-Zuteilung |
10,000 |
$22.10 |
$221K |
10,000 |
| 2024-05-20 |
Cook Robert Christopher |
SVP & General Counsel |
RSU-Zuteilung |
10,000 |
$22.10 |
$221K |
10,000 |
| 2024-05-16 |
Robertson Sanford |
Director |
Schenkung (erhalten) |
5,000 |
- |
- |
5,000 |
| 2024-05-09 |
Scannon Patrick J Md Phd |
Director |
RSU-Zuteilung |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Gussin Robert Z |
Director |
RSU-Zuteilung |
15,000 |
$21.11 |
$316.65K |
15,000 |
| 2024-05-09 |
O Donnell Michael J |
Director |
RSU-Zuteilung |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Robertson Sanford |
Director |
RSU-Zuteilung |
15,000 |
$21.11 |
$316.65K |
15,000 |
| 2024-05-09 |
Barry Richard |
Director |
RSU-Zuteilung |
15,000 |
$21.11 |
$316.65K |
15,000 |
| 2024-05-09 |
Nicaise Claude |
Director |
RSU-Zuteilung |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Gravier Pierre |
Director |
RSU-Zuteilung |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-05-09 |
Anderson Robert Eugene Jr |
Director |
RSU-Zuteilung |
10,000 |
$21.11 |
$211.1K |
10,000 |
| 2024-04-26 |
Robertson Sanford |
Director |
Optionsausübung (Verkauf) |
46,000 |
$33.00 |
$1.52M |
308,740 |
| 2024-04-23 |
Barry Richard |
Director |
Optionsausübung (Verkauf) |
117,390 |
$33.00 |
$3.87M |
- |
| 2024-04-18 |
Kupiec James William |
Chief Medical Officer |
Optionsausübung (Verkauf) |
1,000 |
$33.00 |
$33K |
- |
| 2024-04-17 |
Schoen Eric |
Chief Financial Officer |
Optionsausübung (Verkauf) |
1,000 |
$33.00 |
$33K |
6,920 |
| 2024-01-03 |
Schoen Eric |
Chief Financial Officer |
RSU-Zuteilung |
800 |
$33.00 |
$26.4K |
800 |
| 2024-01-03 |
Kupiec James William |
Chief Medical Officer |
RSU-Zuteilung |
1,000 |
$33.00 |
$33K |
1,000 |
| 2024-01-03 |
Barry Richard |
Director |
RSU-Zuteilung |
117,390 |
$33.00 |
$3.87M |
176,085 |
| 2024-01-03 |
Robertson Sanford |
Director |
RSU-Zuteilung |
72,000 |
$33.00 |
$2.38M |
72,000 |
| 2023-12-06 |
Gravier Pierre |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-12-06 |
Gravier Pierre |
Director |
RSU-Zuteilung |
20,000 |
$21.71 |
$434.2K |
20,000 |
| 2023-12-06 |
Anderson Robert Eugene Jr |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-12-06 |
Anderson Robert Eugene Jr |
Director |
RSU-Zuteilung |
20,000 |
$21.71 |
$434.2K |
20,000 |
| 2023-12-06 |
Nicaise Claude |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-12-06 |
Nicaise Claude |
Director |
RSU-Zuteilung |
20,000 |
$21.71 |
$434.2K |
20,000 |
| 2023-10-03 |
Barbier Remi |
President & CEO |
RSU-Zuteilung |
150,000 |
$17.54 |
$2.63M |
150,000 |
| 2023-10-03 |
Schoen Eric |
Chief Financial Officer |
RSU-Zuteilung |
150,000 |
$17.54 |
$2.63M |
150,000 |
| 2023-10-03 |
Kupiec James William |
Chief Medical Officer |
RSU-Zuteilung |
150,000 |
$17.54 |
$2.63M |
150,000 |
| 2023-10-03 |
Cook Robert Christopher |
SVP & General Counsel |
RSU-Zuteilung |
50,000 |
$17.54 |
$877K |
50,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
